CLEARSIGN TECHNOLOGIES CORP (CLIR)

US1850641028 - Common Stock

0.7359  +0.05 (+6.64%)

After market: 0.7063 -0.03 (-4.02%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CLIR. CLIR was compared to 132 industry peers in the Machinery industry. While CLIR has a great health rating, there are worries on its profitability. While showing a medium growth rate, CLIR is valued expensive at the moment.



1

1. Profitability

1.1 Basic Checks

CLIR had negative earnings in the past year.
In the past year CLIR has reported a negative cash flow from operations.
CLIR had negative earnings in each of the past 5 years.
In the past 5 years CLIR always reported negative operating cash flow.

1.2 Ratios

With a Return On Assets value of -61.78%, CLIR is not doing good in the industry: 91.54% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -93.45%, CLIR is doing worse than 87.69% of the companies in the same industry.
Industry RankSector Rank
ROA -61.78%
ROE -93.45%
ROIC N/A
ROA(3y)-66.29%
ROA(5y)-65.47%
ROE(3y)-75.91%
ROE(5y)-75.17%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

CLIR has a Gross Margin of 21.19%. This is in the lower half of the industry: CLIR underperforms 70.00% of its industry peers.
CLIR's Gross Margin has improved in the last couple of years.
CLIR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 21.19%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y1.82%

7

2. Health

2.1 Basic Checks

CLIR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CLIR has more shares outstanding
CLIR has more shares outstanding than it did 5 years ago.
There is no outstanding debt for CLIR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

Based on the Altman-Z score of -9.21, we must say that CLIR is in the distress zone and has some risk of bankruptcy.
CLIR has a worse Altman-Z score (-9.21) than 93.08% of its industry peers.
There is no outstanding debt for CLIR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -9.21
ROIC/WACCN/A
WACC8.37%

2.3 Liquidity

A Current Ratio of 2.72 indicates that CLIR has no problem at all paying its short term obligations.
With a decent Current ratio value of 2.72, CLIR is doing good in the industry, outperforming 70.77% of the companies in the same industry.
CLIR has a Quick Ratio of 2.72. This indicates that CLIR is financially healthy and has no problem in meeting its short term obligations.
CLIR has a better Quick ratio (2.72) than 85.38% of its industry peers.
Industry RankSector Rank
Current Ratio 2.72
Quick Ratio 2.72

4

3. Growth

3.1 Past

CLIR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 36.00%, which is quite impressive.
The Revenue for CLIR has decreased by -39.34% in the past year. This is quite bad
The Revenue has been decreasing by -7.28% on average over the past years.
EPS 1Y (TTM)36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)-39.34%
Revenue growth 3YN/A
Revenue growth 5Y-7.28%
Sales Q2Q%-70%

3.2 Future

CLIR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 35.77% yearly.
CLIR is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 184.68% yearly.
EPS Next Y4.37%
EPS Next 2Y5.24%
EPS Next 3Y32.36%
EPS Next 5Y35.77%
Revenue Next Year363.11%
Revenue Next 2Y275.56%
Revenue Next 3Y296.22%
Revenue Next 5Y184.68%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

CLIR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year CLIR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as CLIR's earnings are expected to grow with 32.36% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y5.24%
EPS Next 3Y32.36%

0

5. Dividend

5.1 Amount

CLIR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CLEARSIGN TECHNOLOGIES CORP

NASDAQ:CLIR (9/6/2024, 8:05:38 PM)

After market: 0.7063 -0.03 (-4.02%)

0.7359

+0.05 (+6.64%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap36.62M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -61.78%
ROE -93.45%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 21.19%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.72
Quick Ratio 2.72
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)36%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y4.37%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-39.34%
Revenue growth 3YN/A
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y